Real-World Use of Symptomatic Treatments in Early Alzheimer's Disease.

ABSTRACT:

Background

Alzheimer's disease (AD) is the most common type of dementia, causing progressive decline of memory, thinking, and behavior, impairing daily functioning. Early AD (eAD) includes mild cognitive impairment (MCI) due to AD and mild AD dementia.

Objective

The aim of this study was to investigate symptomatic treatment prevalence and treatment patterns in eAD.

Methods

Embase, MEDLINE, and EBM Reviews were searched in November 2021 for observational studies reporting symptomatic treatment patterns in eAD. The range of patients receiving treatment was collated. Risk of bias was assessed using the Joanna Briggs Institute (JBI) prevalence tool. Two independent reviewers screened the records, one performed data extraction and quality assessment while a second checked.

SUBMITTER: Garcia MJ 

PROVIDER: S-EPMC9881030 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature